- Companies
- CelLBxHealth
CelLBxHealth Valuation Multiples
CelLBxHealth is valued at $9M as of November 2026, a 3.0x revenue multiple. In the last 12 months, CelLBxHealth revenue was $2M and CelLBxHealth EBITDA was ($9M).
CelLBxHealth Overview
About CelLBxHealth
CelLBxHealth PLC is engaged in the development and commercialisation of the Parsortix platform, with deployment in liquid biopsy - non-invasive cancer diagnostics. It operates in single segment of commercialisation of its Parsortix cell separation platform. It generates revenue from contracts with customers in the research-use market, with customers located across multiple geographic regions. Geographically it operates in UK, Europe, North America, and Rest of World with majority of revenue deriving from Europe and North America.
Founded
2003
HQ
Employees
114
Website
Financials (LTM)
EV
$7M
Valuation Multiples
Start free trialCelLBxHealth Financials
CelLBxHealth reported last 12-month revenue of $2M and negative EBITDA of ($9M).
In the same LTM period, CelLBxHealth generated $2M in gross profit, ($9M) in EBITDA losses, and had net loss of ($10M).
Revenue (LTM)
CelLBxHealth P&L
In the most recent fiscal year, CelLBxHealth reported revenue of $2M and EBITDA of ($21M).
CelLBxHealth is unprofitable as of last fiscal year, with gross margin of 62%, EBITDA margin of (1175%), and net margin of (1444%).
Financial data powered by Morningstar, Inc.
CelLBxHealth Stock Performance
CelLBxHealth has current market cap of $9M, and enterprise value of $7M.
Market Cap Evolution
CelLBxHealth's stock price is $0.01.
CelLBxHealth share price decreased by 1.3% in the last 30 days.
CelLBxHealth has an EPS (earnings per share) of $-0.02.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $7M | $9M | -0.0% | -1.3% | -53.3% | - | $-0.02 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCelLBxHealth Valuation Multiples
CelLBxHealth trades at 3.0x EV/Revenue multiple, and (0.8x) EV/EBITDA.
EV / Revenue (LTM)
CelLBxHealth Financial Valuation Multiples
As of November 19, 2026, CelLBxHealth has market cap of $9M and EV of $7M.
CelLBxHealth has a P/E ratio of (0.9x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified CelLBxHealth Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


CelLBxHealth Margins & Growth Rates
CelLBxHealth grew revenue by 33% but EBITDA decreased by 66% in the last fiscal year.
In the most recent fiscal year, CelLBxHealth reported gross margin of 62%, EBITDA margin of (1175%), and net margin of (1444%).
CelLBxHealth Margins
CelLBxHealth Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
CelLBxHealth Operational KPIs
CelLBxHealth's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.2M for the same period.
CelLBxHealth's Rule of 40 is (267%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
CelLBxHealth's Rule of X is (218%) (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
CelLBxHealth Competitors
CelLBxHealth competitors include DiagnosTear Technologies, Lifeward, EZZ Life Science, Pulsenmore, Iridex, Allmed Solutions, Spineguard, Renerve, Iconovo and ViroGates.
Most CelLBxHealth public comparables operate across Medical Devices, Diagnostics & Genomics, BioTech and DeepTech.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| - | ($2M) | - | - | (3.6x) | - | |||
| $22M | ($19M) | 0.3x | 0.3x | (0.3x) | - | |||
| $31M | ($4M) | 0.1x | 0.1x | (0.7x) | - | |||
| $12M | ($5M) | - | - | - | - | |||
| $53M | ($1M) | 0.4x | 0.4x | (18.1x) | (992.9x) | |||
| - | ($5M) | - | - | (0.5x) | - | |||
| $4M | ($1M) | 2.5x | 3.0x | (6.9x) | (9.6x) | |||
| $344K | ($4M) | 25.0x | - | (2.3x) | - | |||
This data is available for Pro users. Sign up to see all CelLBxHealth competitors and their valuation data. Start Free Trial | ||||||||
Acquisitions by CelLBxHealth
CelLBxHealth has acquired 1 company to date.
Last acquisition by CelLBxHealth was on November 1st 2017. CelLBxHealth acquired Axela, Inc for undisclosed valuation.
Latest Acquisitions by CelLBxHealth
| Description | Axela, Inc. is a Toronto-based life sciences firm delivering multiplex analysis platforms for proteins, DNA, and RNA in biomarker testing and infectious disease research. Its commercial portfolio includes bead-based instruments, sensors, chips, reagents, and software applications, distributed globally through life sciences and clinical partners. Specific biomarker assays and methods are licensed to diagnostic and industry collaborators to advance personalized medicine. |
| HQ Country | |
| HQ City | Toronto |
| Deal Date | 1 Nov 2017 |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all CelLBxHealth acquisitions and their M&A valuation multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout CelLBxHealth
| When was CelLBxHealth founded? | CelLBxHealth was founded in 2003. |
| Where is CelLBxHealth headquartered? | CelLBxHealth is headquartered in United Kingdom. |
| How many employees does CelLBxHealth have? | As of today, CelLBxHealth has over 114 employees. |
| Who is the CEO of CelLBxHealth? | CelLBxHealth's CEO is Peter Collins. |
| Is CelLBxHealth publicly listed? | Yes, CelLBxHealth is a public company listed on London Stock Exchange. |
| What is the stock symbol of CelLBxHealth? | CelLBxHealth trades under CLBX ticker. |
| When did CelLBxHealth go public? | CelLBxHealth went public in 2004. |
| Who are competitors of CelLBxHealth? | CelLBxHealth main competitors include DiagnosTear Technologies, Lifeward, EZZ Life Science, Pulsenmore, Iridex, Allmed Solutions, Spineguard, Renerve, Iconovo, ViroGates. |
| What is the current market cap of CelLBxHealth? | CelLBxHealth's current market cap is $9M. |
| What is the current revenue of CelLBxHealth? | CelLBxHealth's last 12 months revenue is $2M. |
| What is the current revenue growth of CelLBxHealth? | CelLBxHealth revenue growth (NTM/LTM) is 79%. |
| What is the current EV/Revenue multiple of CelLBxHealth? | Current revenue multiple of CelLBxHealth is 3.0x. |
| Is CelLBxHealth profitable? | No, CelLBxHealth is not profitable. |
| What is the current EBITDA of CelLBxHealth? | CelLBxHealth has negative EBITDA and is not profitable. |
| What is CelLBxHealth's EBITDA margin? | CelLBxHealth's last 12 months EBITDA margin is (375%). |
| What is the current EV/EBITDA multiple of CelLBxHealth? | Current EBITDA multiple of CelLBxHealth is (0.8x). |
| What is the current FCF of CelLBxHealth? | CelLBxHealth's last 12 months FCF is ($9M). |
| What is CelLBxHealth's FCF margin? | CelLBxHealth's last 12 months FCF margin is (391%). |
| What is the current EV/FCF multiple of CelLBxHealth? | Current FCF multiple of CelLBxHealth is (0.8x). |
| How many companies CelLBxHealth has acquired to date? | As of November 2026, CelLBxHealth has acquired 1 company. |
| What was the largest acquisition by CelLBxHealth? | None of the M&A deals CelLBxHealth has completed have disclosed valuations. |
| What companies CelLBxHealth acquired? | CelLBxHealth acquired Axela, Inc. |
| In how many companies CelLBxHealth has invested to date? | CelLBxHealth hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to CelLBxHealth
Lists including CelLBxHealth
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




